Pediatric Orthopedics for Primary Healthcare
Evidence-Based Practice
Page
%P
-
Article
Open AccessAnalysis of disease characteristics of a large patient cohort with congenital generalized lipodystrophy from the Middle East and North Africa
Congenital generalized lipodystrophy (CGL) is a rare inherited disease characterized by a near-total absence of adipose tissue and is associated with organ system abnormalities and severe metabolic complicatio...
-
Article
Open AccessThe genomic landscape of rare disorders in the Middle East
Rare diseases collectively impose a significant burden on healthcare systems, especially in underserved regions, like the Middle East, which lack access to genomic diagnostic services and the associated person...
-
Chapter
Metabolic Bone Disease
This chapter examines bone physiology and biochemistry and the diseases that result from disturbed function. Some disorders such as rickets and osteoporosis are comparatively common in children and every gener...
-
Book
-
Article
Open AccessClinical Use of Degludec in Children and Adolescents with T1D: A Narrative Review with Fictionalized Case Reports
The use of insulin in children and adolescents with type 1 diabetes (T1D) is a challenge because of the heterogeneity of these patients and their lifestyles, with consequent unpredictability in blood glucose l...
-
Article
Open AccessHealthcare Resource Utilization and Costs Associated with Ketosis Events in Pediatric and Adult Patients with Type 1 Diabetes Mellitus in the UK
Ketosis is a metabolic state associated with insulin deficiency. Untreated, it develops into diabetic ketoacidosis, a significant contributor to mortality and morbidity in people with type 1 diabetes mellitus ...
-
Article
Open AccessDevelopment of Insulin Detemir/Insulin Aspart Cross-Reacting Antibodies Following Treatment with Insulin Detemir: 104-week Study in Children and Adolescents with Type 1 Diabetes Aged 2–16 Years
To study the long-term development (104 weeks) of insulin antibodies during treatment with insulin detemir (IDet) and insulin aspart (IAsp) in children with type 1 diabetes aged 2–16 years.
-
Article
Intravenous immunoglobulins for the management of Stevens-Johnson syndrome with minimal skin manifestations
Here we describe the successful use of intravenous immunoglobulin (IVIG) in the management of mycoplasma-induced, atypical Stevens-Johnson syndrome (SJS) with minimal skin manifestations. The patient was succe...
